Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sulfur Hexafluoride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,411Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of November 30, 2022
    Enforcement Report - Week of November 30, 2022

    30 Nov 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-30-2022-40173.pdf

    FDA
    30 Nov 2022
    Share Share
    The FDA removes the contraindication for use of Bracco Diagnostics's LUMASON
    The FDA removes the contraindication for use of Bracco Diagnostics's LUMASON

    12 Jan 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/the-fda-removes-the-contraindication-for-use-of-bracco-diagnostics-incs-lumason-sulfur-hexafluoride-lipid-type-a-microspheres-for-injectable-suspension-for-intravenous-use-or-intravesical-use-in-patients-with-cardiac-shunts-300388840.html

    PR NEWSWIRE
    12 Jan 2017
    Share Share
    First Approval by U.S. FDA for Contrast Enhanced Ultrasonography
    First Approval by U.S. FDA for Contrast Enhanced Ultrasonography

    04 Apr 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/first-approval-by-us-food-and-drug-administration-for-contrast-enhanced-ultrasonography-of-the-liver-received-by-bracco-diagnostics-inc-for-lumason-sulfur-hexafluoride-lipid-type-a-microspheres-for-injectable-suspension-for-300245196.html

    PR NEWSWIRE
    04 Apr 2016
    Share Share